|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.27 USD | -1.74% |
|
-3.55% | +1.65% |
| 07-14 | Conmed Shares Rise After Company Mulls Sale Amid Takeover Interest | MT |
| 07-13 | Conmed Shares Rise After Company Mulls Sale Amid Takeover Interest | MT |
Company Valuation: CONMED Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,146 | 2,702 | 3,368 | 2,114 | 1,257 | 1,265 | - | - |
| Change | - | -34.83% | 24.64% | -37.22% | -40.53% | 0.58% | - | - |
| Enterprise Value (EV) 1 | 4,810 | 3,728 | 4,317 | 2,995 | 2,051 | 1,959 | 1,844 | 1,717 |
| Change | - | -22.5% | 15.81% | -30.62% | -31.52% | -4.53% | -5.87% | -6.88% |
| P/E | 73.1x | -33.1x | 53.7x | 16.1x | 26.9x | 10.4x | 8.9x | 8x |
| PBR | 5.26x | 3.57x | 4.04x | 2.2x | 1.1x | 1.05x | 0.92x | 0.81x |
| PEG | - | 0x | -0x | 0x | -0.4x | 0x | 0.5x | 0.7x |
| Capitalization / Revenue | 4.1x | 2.58x | 2.71x | 1.62x | 0.91x | 0.93x | 0.88x | 0.84x |
| EV / Revenue | 4.76x | 3.57x | 3.47x | 2.29x | 1.49x | 1.44x | 1.29x | 1.13x |
| EV / EBITDA | 24.4x | 19.8x | 18.3x | 11.3x | 7.44x | 7.19x | 6.3x | 6.19x |
| EV / EBIT | 33.6x | 28.4x | 24.8x | 14.8x | 9.5x | 9.65x | 8.33x | 6.97x |
| EV / FCF | 49.6x | 322x | 40.6x | 19.5x | 13.6x | 10.1x | 11.3x | 9.87x |
| FCF Yield | 2.01% | 0.31% | 2.46% | 5.14% | 7.36% | 9.94% | 8.89% | 10.1% |
| Dividend per Share 2 | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | - | - | - |
| Rate of return | 0.56% | 0.9% | 0.73% | 1.17% | 1.97% | - | - | - |
| EPS 2 | 1.94 | -2.68 | 2.04 | 4.25 | 1.51 | 3.98 | 4.635 | 5.16 |
| Distribution rate | 41.2% | -29.9% | 39.2% | 18.8% | 53% | - | - | - |
| Net sales 1 | 1,011 | 1,045 | 1,245 | 1,307 | 1,375 | 1,362 | 1,434 | 1,514 |
| EBITDA 1 | 197.2 | 188.7 | 235.4 | 265.6 | 275.9 | 272.3 | 292.9 | 277.2 |
| EBIT 1 | 143.3 | 131.3 | 174.4 | 202.8 | 216 | 203 | 221.4 | 246.4 |
| Net income 1 | 62.54 | -80.58 | 64.46 | 132.4 | 47.06 | 120.5 | 140.1 | 153.6 |
| Net Debt 1 | 663.8 | 1,026 | 949.6 | 881.3 | 794.1 | 694 | 579 | 452.2 |
| Reference price 2 | 141.76 | 88.64 | 109.51 | 68.44 | 40.60 | 41.27 | 41.27 | 41.27 |
| Nbr of stocks (in thousands) | 29,247 | 30,482 | 30,752 | 30,891 | 30,968 | 30,109 | - | - |
| Announcement Date | 26/01/22 | 02/02/23 | 31/01/24 | 05/02/25 | 28/01/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 10.55x | 1.44x | 7.19x | -.--% | 1.26B | |
| 28.06x | 3.95x | 15.35x | 2.57% | 175B | |
| 18.58x | 3.26x | 11.47x | 3.63% | 105B | |
| 16.72x | 0.19x | 11.83x | 0.79% | 58.48B | |
| 31.6x | 7.68x | 20.06x | 1.27% | 51.36B | |
| 38.16x | 3.06x | 10.42x | 2.51% | 42.2B | |
| 35.64x | 1.32x | 11.59x | 0.28% | 31.44B | |
| 29.18x | 5.19x | 16.57x | -.--% | 27.56B | |
| 42.59x | 7.45x | 26.87x | 0.24% | 25.32B | |
| 23.19x | 3.39x | 12.2x | 1.25% | 20.52B | |
| Average | 27.43x | 3.69x | 14.36x | 1.25% | 53.82B | |
| Weighted average by Cap. | 27.07x | 3.74x | 14.52x | 2.02% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CNMD Stock
- Valuation CONMED Corporation
Select your edition
All financial news and data tailored to specific country editions
